Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000192312 | SCV000246888 | uncertain significance | not specified | 2014-12-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764187 | SCV000895189 | uncertain significance | Intellectual disability, autosomal recessive 3 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001093046 | SCV001249844 | uncertain significance | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001093046 | SCV004265284 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000764187 | SCV004563270 | uncertain significance | Intellectual disability, autosomal recessive 3 | 2023-09-27 | criteria provided, single submitter | clinical testing | The CC2D1A c.2342G>C; p.Gly781Ala variant (rs2092723475), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 210600). Due to limited information, the clinical significance of this variant is uncertain at this time. |
Prevention |
RCV003927770 | SCV004738208 | likely benign | CC2D1A-related disorder | 2022-10-24 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |